ENTITY
Shenzhen Chipscreen Bioscience

Shenzhen Chipscreen Bioscience (688321 CH)

24
Analysis
Health CareChina
Shenzhen Chipscreen Biosciences Co., Ltd. operates as a drug development company. The Company produces and sells anticancer drugs, immunological disease therapeutic drugs, metabolic disease therapeutic drugs, and other products. Shenzhen Chipscreen Biosciences markets its products throughout China.
more
Refresh
03 Mar 2024 05:40

Index Rebalance & ETF Flow Recap: STAR50/100, FXI, NIFTY/NEXT50, S&P500, KOSPI, Goodman, Ecopro BM

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
858 Views
Share
25 Feb 2024 15:40

STAR100 Index Rebalance: Ten Changes a Side; Adds Outperforming as Expected

There are 10 changes a side for the STAR100 Index in March. Estimated one-way turnover is 6.8% resulting in a one-way trade of CNY 1.79bn. The adds...

Logo
481 Views
Share
bearishInfosys Ltd
11 Feb 2024 05:50

Index Rebalance & ETF Flow Recap: STAR100, NEXT50, LowVol30, KOSPI200, TW50, NWD, ITC, India Float

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
530 Views
Share
06 Feb 2024 06:10

STAR100 Index Rebalance Preview: High Risk/Return Trade Setup

There could be 10 changes for the STAR50 Index in March. The potential adds and deletes have over 2x ADV to trade on average and given the...

Logo
454 Views
Share
05 Mar 2023 09:00

China Healthcare Weekly (March.3) - TCM New Policy, Pfizer to Acquire Seagen, Haohai Biological

New favorable policy for TCM industry was released. We analyzed our top picks. Pfizer is in talks to acquire Seagen, but we're conservative about...

Logo
475 Views
Share
x